Previous studies have demonstrated that aspirin and compound C (an AMPK inhibitor) inhibit the expression of FA synthesis-related enzymes via C-MYC, thereby impeding HER2+ BC 38, 39. The gene discussed is ERBB2; the disease is breast cancer.